Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03214536Completed
Open-label, single-arm trial of ropivacaine in postoperative pain. Primary endpoint: 24 hour opioid consumption. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03214536.